Dr. Ellenbroek is principle scientist neuropharmacology, working within the in vivo pharmacological group. He joined Evotec in 2006 after having worked in academia as an in vivo neuropharmacologist for over 15 years. His work focuses on in vivo animal modeling with special interest in animal models for CNS disorders, including Parkinson’s disease. Currently, he is involved in establishing and validating animal models for cognitive deficits, Huntington’s disease and other psychiatric and neurological indications.